Substituted sulfamate anticonvulsant derivatives
    6.
    发明授权
    Substituted sulfamate anticonvulsant derivatives 有权
    取代氨基磺酸酯抗惊厥药衍生物

    公开(公告)号:US07560459B2

    公开(公告)日:2009-07-14

    申请号:US11265670

    申请日:2005-11-02

    IPC分类号: A61K31/255 C07C311/01

    CPC分类号: C07H5/06 C07H9/04

    摘要: The present invention is directed to novel compounds of the formula (I) wherein X, R1, R2, R3, R4, R5 and R6 are as described in the specification, processes for the preparation of and pharmaceutical compositions comprising said derivatives. The compounds of the present invention are useful for the treatment of epilepsy.The invention is further directed to a process for the preparation of compounds of formula (XX), wherein X, R3, R4, R5 and R6 are as described in the specification.

    摘要翻译: 本发明涉及式(I)的新化合物,其中X,R 1,R 2,R 3,R 4,R 5和R 6如说明书中所述,制备方法和包含所述衍生物的药物组合物。 本发明的化合物可用于治疗癫痫。 本发明还涉及制备式(XX)化合物的方法,其中X,R 3,R 4,R 5和R 6如说明书中所述。

    Liquid phase peptide syntheses of KL-4 pulmonary surfactant
    9.
    发明申请
    Liquid phase peptide syntheses of KL-4 pulmonary surfactant 审中-公开
    KL-4肺表面活性剂的液相肽合成

    公开(公告)号:US20070149765A1

    公开(公告)日:2007-06-28

    申请号:US11581925

    申请日:2006-10-17

    申请人: Ahmed Abdel-Magid

    发明人: Ahmed Abdel-Magid

    IPC分类号: C07K7/08

    摘要: The invention realtes to improved liquid phase processes for the preparation of the 21 residue protein component, (Lys-Leu4)4-Lys, of the pulmonary surfactant KL-4. These process are amenable to large scale synthesis and one process employs a method of saponifying an ester which reduces the inherent racemization of the α-carbon.

    摘要翻译: 本发明涉及用于制备肺表面活性剂KL-4的21残基蛋白组分(Lys-Leu 4 N 4)4 -Sys的改进的液相方法。 这些方法适合于大规模合成,一种方法采用皂化方法来降低α-碳的固有外消旋化。